Molecular understanding of oxygen-tension and patient-variability effects on ex vivo expanded T cells

Biotechnol Bioeng. 2004 Aug 20;87(4):437-50. doi: 10.1002/bit.20166.

Abstract

Immunotherapy with ex vivo cultured T cells depends on a large supply of biologically active cells. Understanding the effects of culture parameters is essential for improving the proliferation and efficacy of the expanded cells. Low oxygen tension (5% pO(2)) was previously reported to improve T-cell expansion and alter cellular phenotypic characteristics compared to T cells cultured at 20% pO(2). Here we report the use of DNA-array based transcriptional analysis coupled with protein-level analysis to provide molecular insights into pO(2) and patient-variability effects on expanded primary human T cells. Analysis of seven blood samples showed that reduced pO(2) results in higher expression of genes important in lymphocyte biology, immune function, and cell-cycle progression. 20% pO(2) resulted in higher expression of genes involved in stress response, cell death, and cellular repair. Expression of granzyme A (gzmA) was found to be significantly regulated by oxygen tension with cells at 5% pO(2) having greater gzmA expression than at 20% pO(2). Protein-level analysis of gzmA was consistent with transcriptional analysis. Granzyme K (gzmK) was coexpressed with gzmA, whereas Granzyme B (gzmB) expression was found to precede the expression of both gzmA and gzmK in 15-day cultures. Temporal gene expression patterns for seven blood samples demonstrate that most genes are expressed by all patient samples in similar temporal patterns. However, several patient-specific gene clusters were identified, and one cluster was found to correlate well with cell proliferation and may potentially be used to predict patient-specific T-cell expansion.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Cell Culture Techniques / methods*
  • Cell Proliferation
  • Cell- and Tissue-Based Therapy / methods
  • Cells, Cultured
  • Gene Expression Regulation / genetics*
  • Genetic Variation
  • Hemochromatosis / genetics*
  • Hemochromatosis / metabolism*
  • Humans
  • Immunotherapy / methods
  • Oligonucleotide Array Sequence Analysis / methods*
  • Oxygen / metabolism*
  • T-Lymphocytes / metabolism*

Substances

  • Oxygen